...
首页> 外文期刊>Maturitas: International Journal for the Study of the Climacteric >EMAS position statement: Testosterone replacement therapy in the aging male
【24h】

EMAS position statement: Testosterone replacement therapy in the aging male

机译:EMAS立场声明:睾酮替代疗法在老龄化男性中

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Introduction: Late-onset hypogonadism (LOH) represents a common clinical entity in aging males, characterized by the presence of symptoms (most usually of a sexual nature, such as decreased libido, decreased spontaneous erections and erectile dysfunction) and signs, in combination with low serum testosterone concentrations. Whether testosterone replacement therapy (TRT) should be offered to those individuals is still under extensive debate.
机译:介绍:晚期后性腺后性腺(LOH)代表老年男性的常见临床实体,其特征在于症状的存在(通常是性质,例如降低性欲下降,减少自发性勃起和勃起功能障碍)和标志,与 低血清睾酮浓度。 是否应向这些个人提供睾酮替代疗法(TRT)仍处于广泛的辩论。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号